Ledger.Open graph →
SEC Form D · filed February 13, 2019

Nayan Therapeutics, Inc

Offering
$25.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
MEDFIELD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Milind Deshpande · Cambridge, MAExec · DirectorDavid Neafus · Cambridge, MAExecJoshua Resnick · Needham, MADirectorRobert Millman · Boston, MADirector · PromoterMilind Deshpande · Cambridge, MAExec · DirectorJoshua Resnick · Los Angeles, CADirectorRobert Millman · MEDFIELD, MADirector · PromoterDavid Neafus · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗